ALGN Add to watchlist $173.86 2.18 (-1.24%) Last updated: Aug 11, 2026 19:52
52-Week Range
$173.86
$122.00 $173.86 $200.44

Fundamentals Overview

Align Technology, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 30.1 P/S 3.01

Intrinsic value (DCF)

-49.2% downside vs price

Profitability

Net margin 10%

Risk (Beta)

1.65 — higher vol

Earnings & growth

EPS $5.77 Rev +1.5% Profit -4% vs prior qtr

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 68% confidence Risk: High Volatility — Beta 1.65. Consider smaller position size due to higher beta.

Supporting (Buy):

Analyst grade: A-

Pressures (Sell):

DCF 49.2% downside vs price · 3M vs Healthcare sector: -14% · Beta 1.65 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$12.45B
P/E (TTM)
30.11
EPS (TTM)
$5.77
Dividend Yield
N/A
52-Week Range
$122.00 - $200.44
Volume vs Avg
N/A
Beta
1.65

About

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." ...
Sector: Healthcare
Headquarters: US
Employees: 20,435
IPO Date: Jan 2001
Beta: 1.65 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: mixed. Current institutional positions: Buy: 3, Equal Weight: 6, Hold: 2, Neutral: 2, Outperform: 8, Overweight: 9.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $88.25; current price is $173.86. That’s a -49.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 30.11
DCF value (model) $88.25 (-49.2% vs price)
PEG (TTM) N/A
P/B (TTM) N/A
P/S (TTM) 3.01
P/FCF (TTM) 16.48
Liquidity & enterprise
Current Ratio (TTM) 1.4
Quick Ratio (TTM) 1.28
Cash Ratio (TTM) 0.58
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 9.99%
Gross margin (TTM) 66.48%
Operating margin (TTM) 13.33%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ALGN.

Analyst Sentiment at a Glance

A- Sentiment Mixed
Buy 3Equal Weight 6Hold 2Neutral 2Outperform 8Overweight 9
2 upgrades, 2 downgrades
Price Target Consensus
Current $173.86
Median $200.00
Consensus $204.20
Low consensus $188.00
High consensus $235.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-04-30
Morgan Stanley maintain Equal Weight Equal Weight 2026-04-24
Piper Sandler maintain Overweight Overweight 2026-04-21
Barclays upgrade Equal Weight Overweight 2026-03-17
Barclays maintain Equal Weight Equal Weight 2026-02-26
HSBC upgrade Hold Buy 2026-02-09
Piper Sandler maintain Overweight Overweight 2026-02-05
Morgan Stanley maintain Equal Weight Equal Weight 2026-02-05
Wells Fargo maintain Overweight Overweight 2026-02-05
UBS maintain Neutral Neutral 2026-02-05
Stifel maintain Buy Buy 2026-02-05
Evercore ISI Group maintain Outperform Outperform 2026-02-05
Mizuho maintain Outperform Outperform 2026-01-20
Evercore ISI Group maintain Outperform Outperform 2025-10-30
Morgan Stanley maintain Equal Weight Equal Weight 2025-10-30
Wells Fargo maintain Overweight Overweight 2025-10-30
Piper Sandler maintain Overweight Overweight 2025-10-30
Morgan Stanley maintain Equal Weight Equal Weight 2025-10-21
UBS maintain Neutral Neutral 2025-10-16
Mizuho maintain Outperform Outperform 2025-10-13
Jefferies downgrade Buy Hold 2025-10-10
Evercore ISI Group maintain Outperform Outperform 2025-10-08
Morgan Stanley downgrade Overweight Equal Weight 2025-07-31
Stifel maintain Buy Buy 2025-07-31
Piper Sandler maintain Overweight Overweight 2025-07-31
Wells Fargo maintain Overweight Overweight 2025-07-31
Evercore ISI Group maintain Outperform Outperform 2025-07-09
Evercore ISI Group maintain Outperform Outperform 2025-05-01
Needham maintain Hold Hold 2025-05-01
Piper Sandler maintain Overweight Overweight 2025-05-01